Mind Medicine (MMED.E) started enrolling candidates for further human safety trial studies of 18-MC, the company’s orally taken ibogaine derivative for the treatment of opioid addiction. Clinical studies for…
opiods
According NEJM Journal Watch – a physician-focused website – “20% of deaths among U.S. adults aged 25 to 34 years are related to opioid use.” US millennials are dying…
The Investment Industry Regulatory Organization of Canada (IIROC) recommends a “quiet period” after a company announces its intention to raise money. This reduces the possibility that private placement participants…
The U.S. Department of Justice (DOJ) is the subject of “Friday’s Big Fail”. Yah, we could bust the DOJ up for its on-going attempt to keep marijuana illegal, but…
Twenty-five years ago, a drug overdose victim was typically from an inner city neighbourhood. No longer. Like a cloud of mustard gas, drug addiction has swept across the manicured…